In light of recent wins for mRNA vaccine makers, UCSC RNA Center Co-Director Jeremy Sanford describes the versatility of the ...
New research by Malaghan's Connor Laboratory, published in PNAS, shows how directing the immune system toward conserved areas of the COVID virus and its many variants using RNA technology could be a ...
Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process ...
This flu shot, mFlusiva, was shown in a clinical trial to be up to 27 percent more effective than a standard flu jab ...
Every RNA virus — from stomach bugs and influenza to chickenpox and the common cold — has its own story to tell, with a ...
The FDA approved an mRNA seasonal influenza vaccine offering enhanced protection for adults aged 50 years or older compared with standard vaccines. The Conversation — Vaccines have been reliably and ...
Programmable nucleic acid nanoparticles boost vaccine immune responses as effectively as standard adjuvants in mice while avoiding the autoimmune risks that limit existing alternatives. (Nanowerk ...
Moderna and Merck's personalised mRNA cancer vaccine lowers melanoma recurrence, marking a breakthrough in targeted cancer treatment research. Read more at straitstimes.com. Read more at straitstimes.
Connie Franciosi, 80, noticed a suspicious spot on her skin and was diagnosed with melanoma in 2020. "It was considered a late diagnosis," she says. The skin cancer can be difficult to treat if it's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results